Knopp Neurosciences Inc.

Knopp Neurosciences is developing the right-oriented enantiomer of Parkinson's and restless leg syndrome drug pramipexole (Mirapex) for amyotrophic lateral sclerosis. The drug has received orphan designation from the FDA, and is now in Phase IIa studies in 80 ALS patients.